Peer-reviewed veterinary case report
c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection.
- Journal:
- The Journal of infectious diseases
- Year:
- 2025
- Authors:
- Sarti, Edoardo et al.
- Affiliation:
- Department of Infectious Diseases and Hospital Epidemiology
Abstract
BACKGROUND: Mycobacterium tuberculosis (MTB) remains a major cause of global mortality, yet natural immunity prevents disease in more than 90% of exposed individuals. Interferon gamma (IFN-γ) is a critical regulator of innate immunity and enhances macrophage antimicrobial responses. METHODS: Using in vitro systems approaches, we compared the effects of IFN-γ exposure before versus after infection. We manipulated c-Myc in primary macrophages with a tetracycline-inducible lentiviral system. c-Myc expression was also analyzed in tissues from murine tuberculosis models and human granulomas. RESULTS: Preinfection IFN-γ exposure primed macrophages for enhanced bacterial control, whereas postinfection exposure did not. We identified c-Myc signaling as a central determinant of macrophage antimycobacterial function. Inhibition of c-Myc via Omomyc enhanced bacterial control partly through mTORC1-dependent metabolic reprogramming and nitric oxide production. In vivo analyses, including murine models and human clinical histopathology, revealed strong associations between c-Myc expression, MTB persistence, and active tuberculosis. CONCLUSION: c-Myc mediates immune privilege in MTB infection and represents a promising target for host-directed therapies to enhance macrophage function.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/40884499/